Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Hewlett Packard Enterprise Co (HPE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Hewlett Packard Enterprise Co — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Hewlett Packard Enterprise Co trades at $61.36 (market cap $91.34B). The key difference: Hewlett Packard Enterprise Co is far larger — about 2.9× GE HealthCare Technologies Inc. Common Stock's market cap, and Hewlett Packard Enterprise Co pays the higher dividend (0.83%). Which is the better fit depends on your goals.
| GEHC | HPE | |
|---|---|---|
Market Cap | $31.07B | $91.34B |
Volume | 3,443,020 | 23,977,697 |
Sector | Health | Technology |
52-Week High | $88.16 | $73.46 |
52-Week Low | $59.48 | $20.01 |
Enterprise Value | $39.53B | $105.37B |
Dividend Yield | 0.23% | 0.83% |
Typical Hold Time | — | 34 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
HPE stock trades at $63.17, down 10.14% today but remains near recent highs following strong AI infrastructure demand. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $1.11 exceeding expectations by 19%. Technical indicators show a bullish trend with support at $66 and resistance at $72. Recent news highlights a $1.2 billion AI server order from Vultr and upgraded guidance, driving positive sentiment.
HPE presents growth potential from AI infrastructure expansion and strong earnings momentum, though valuation appears elevated with a P/E of 35.47. Key risks include execution challenges in integrating Juniper Networks and competitive pressures in the server market. Analyst consensus targets $70.00 with 47.5% buy ratings, suggesting moderate upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →
